This helps people with type 2 diabetes maintain better glycemic control and prevents spikes and crashes that can occur with rapid digestion
Tirzepatide Once Weekly for the Treatment of Obesity AMG 133 is a novel bispecific glucose-dependent insulinotropic polypeptide receptor (GIPR) antagonist and glucagon-like peptide-1 (GLP-1) receptor agonist molecule
In 2025, the company delivered a strong +19.93% YoY revenue growth, driven by its immunology leadership: Dupixent ($18.48B) continues to be the primary growth engine with expanding indications and global uptake, while Lantus ($2.03B) and Toujeo ($1.58B) remain important contributors in diabetes, albeit facing competitive and pricing pressures reflecting a clear transition toward specialty medicines
Glucagon-Like Peptide-1 Receptor Agonists During Pregnancy and Lactation
In Mar26, Novo Nordisks Awiqli received the US FDA Approval for Type 2 Diabetes Total Revenue: $51.31B Founded Year: 1973 Total Employees: 74,800 Headquarters: Paris, France Market Cap: $115.94B Stock Exchange: EPA Sanofi is a global biopharma company focused on immunology, vaccines, rare diseases, and specialty care, with a strategic shift toward high-growth biologics and innovative therapies
